Antioxidant Activity and Lipid Peroxidation in Preeclampsia  by Adiga, Usha et al.
J Chin Med Assoc • October 2007 • Vol 70 • No 10 435
Introduction
Preeclampsia is a multisystem disorder that is charac-
terized by hypertension, edema and proteinuria, which
is induced by pregnancy after the 20th week and is a
leading cause of maternal morbidity and mortality.
Endothelial dysfunction may play a pivotal role in the
genesis of the multisystem disorder that develops in
preeclampsia. The mechanisms involved in the induc-
tion of endothelial cell dysfunction are poorly under-
stood. Multiple circulating factors may provoke the
spectrum of endothelial changes, including altered lipo-
proteins. Various studies have reported elevated lipid
levels in preeclamptics.1,2 The changes in the lipid pro-
file are physiologic and are mostly due to the hormonal
variations during pregnancy.3 Normally, the lipid lev-
els come down to those of the prepregnant state in
6–8 weeks in the postpartum period.1,3 Though the
cholesterol levels normalize, the reduction in the risk
of coronary heart disease (CHD) is only 50%.4 Thus,
the risk of CHD in preeclampsia is much higher and
of concern.5
Elevated levels of oxidative lipid derivatives and
reduced antioxidants in the circulation of preeclamp-
tics may contribute to endothelial damage. There is
good evidence for significant increase in the levels of
plasma and erythrocytic malondialdehyde (MDA), a
marker of lipid peroxidation in normotensive preg-
nant women, which were further increased in women
with pregnancy-induced hypertension.6 Evidence of
increased oxidative lipid derivatives in the decidual
placental tissues was observed in women with estab-
lished preelampsia.7 Elevated levels of oxidative lipid
derivatives, conjugated dienes and reduced antioxi-
dative capacity in the maternal circulation have also
been reported.8
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The aim of this study was to elucidate the possible
relation of lipidemic status, lipid peroxidation and




The study was conducted in the city of Mangalore.
Twenty-five preeclamptic patients and 25 normotensive
pregnant women, within the age range of 18–40 years,
admitted to Lady Goshen Hospital and Chirashree
Hospital, in their third trimester, were selected for the
study. Subjects with blood pressure > 140/90 mmHg,
proteinuria and edema were included and eclamptic
patients were excluded from the study. Normal preg-
nant women, diagnosed on clinical and ultrasonography
findings were taken as controls. Patients and controls
were matched for gestational age, maternal age and
parity. Prepregnancy body mass index was in the range
of 19.8–24.4 kg/m2. Elderly primigravid subjects, ges-
tational diabetics, chronic hypertensives, multiple ges-
tations and those with a family history of preeclampsia
were excluded from the study. Subjects also had to be
nonsmokers, nonalcoholics, and not suffering from any
acute infections or chronic illnesses. The demographic
profile of the subjects is shown in Table 1.
All subjects were informed about the objectives of
the study and informed consent was obtained. The study
was approved by the institutional ethics committee.
Sample collection
Five mL of venous blood was collected in EDTA bot-
tles using disposable syringes, after an overnight fast of
12 hours. Plasma was separated and analyzed for MDA,
AOA, total cholesterol (TC), high-density lipoprotein
cholesterol (HDL-C) and albumin. Atherogenic index
(AI) was also calculated.
The oxidant status was studied by estimating MDA
levels.9,10 MDA, a product of lipid peroxidation, reacts
with thiobarbituric acid (TBA) in acidic medium to
give a pink pigment at 97°C and pH 2–3. The pink-
colored complex was extracted with butanol and
absorbance read at 535 nm.
The total AOA was determined by Koracevic et al’s
method.11 The assay measures the capacity of the serum
to inhibit the production of TBA reactive substances
(TBARS) from sodium benzoate, under the influence
of the oxygen free radicals derived from Fenton’s reac-
tion. The reaction was measured spectrophotometri-
cally at 532 nm. Antioxidants from the added sample
cause suppression of the production of TBARS, and the
inhibition of color development is defined as AOA.
TC, HDL-C and albumin were measured by 
enzymatic and colorimetric methods.
Statistical analysis
Statistical analysis was performed using the Mann–
Whitney U test. Correlations between the variables were
estimated by Spearman’s rank correlation coefficients.
Results
Blood pressure, a diagnostic criterion for preeclampsia,
was analyzed in both groups. A significant increase in
blood pressure was observed in preeclamptics compared
to controls (Table 2).
A significant elevation in TC, MDA and AI, and 
a marked diminution in HDL-C, AOA and albumin
levels were observed in preeclamptics (Table 3).
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Table 1. Demographic profile of subjects*
Control subjects Preeclampsia 
(n = 25) subjects (n = 25)
Age (yr) 25.5 ± 3.3 27.5 ± 5.3
Gestational age at 34.3 ± 0.8 33.3 ± 3.6
sampling (wk)
Parity 2 ± 1 2 ± 1
BMI at sampling 20.3 ± 1.9 24.8 ± 2.6
(kg/m2)
*Data are presented as mean ± standard deviation. BMI = body mass index.
Table 2. Blood pressure (BP) of subjects*
Control subjects Preeclampsia  
(n = 25) subjects (n = 25)
Systolic BP (mmHg) 120.32 ± 10.04 181.42 ± 12.94†
Diastolic BP (mmHg) 71.04 ± 6.54 105.2 ± 8.72†
*Data are presented as mean ± standard deviation; †p < 0.001.
Table 3. Oxidant status and lipid profile*
Control subjects Preeclampsia 
(n = 25) subjects (n = 25)
MDA (µmol/L) 6.56 ± 0.73 7.64 ± 0.58†
AOA (mmol/L) 1.40 ± 0.25 1.08 ± 0.15†
TC (mg/dL) 203.0 ± 20.37 246.43 ± 23.87†
HDL-C (mg/dL) 66.33 ± 4.02 48.02 ± 7.40†
Atherogenic index 3.07 ± 0.36 5.25 ± 0.95†
Albumin (g/dL) 3.32 ± 0.35 2.80 ± 0.43†
*Data are presented as mean ± standard deviation; †p < 0.001. MDA = mal-
ondialdehyde; AOA = antioxidant activity; TC = total cholesterol; HDL-C = high-
density lipoprotein cholesterol.
A significant positive association of MDA with
both systolic and diastolic blood pressures was found
in preeclamptics (r = 0.657 for systolic and r = 0.583
for diastolic blood pressure). MDA also bore a sig-
nificant positive correlation with TC in controls
(r = 0.432).
A strong and statistically significant negative cor-
relation was found between AOA and albumin only in
controls (r = –0.502).
Positive correlation between AOA and TC was
observed in both groups (r = 0.114 for controls; r =
0.158 for preeclamptic patients). Similarly, HDL-C
also showed a weak positive correlation with AOA (r =
0.092 for controls; r = 0.040 for patients). However,
these correlations were statistically insignificant.
Discussion
The present study revealed a 20% increase in TC and
27% decrease in HDL-C levels in preeclamptics. The
rise in AI was 70%. Our results are in accordance with
various studies, such as those of Cong et al12 and
Kokia et al.13 Kinnunen et al14 and Alvarez et al15 have
reported decreased lipoprotein lipase and hepatic lipase
activities as possible causes for the lipid changes dur-
ing gestation, which in turn could be attributed to
the heightened insulin resistance and raised estrogen
levels, respectively. Ramsay et al reported that an exag-
gerated insulin resistance observed in preeclampsia
caused further suppression of lipoprotein lipase.16 The
raised estrogen levels coupled with suppression of
lipoprotein lipase may be responsible for the dyslipi-
demia observed in our study. Genetic factors (apoE
polymorphism) have also been found to be related to
lipoprotein lipase activity.17
MDA is significantly elevated in preeclamptics com-
pared to healthy pregnant women (p < 0.001). The
values obtained are in close agreement with those re-
ported by Aydin et al.18 Excessive lipid peroxidation
occurring in preeclampsia can be attributed to hyper-
cholesterolemia. Hypercholesterolemia promotes the
formation of free radicals. Increased oxygen demand
to meet the bodily functions in pregnancy is also a
contributory factor for the oxidative stress that results
in the formation of free radicals. Thus, lipid alterations
observed may promote oxidative stress, leading to
endothelial dysfunction in preeclampsia. Highly signifi-
cant reduction in AOA was observed in the preeclamp-
tic patients in this study. We have not encountered any
study concerning AOA and preeclampsia. The total
antioxidative serum capacity is not a simple sum of the
activities of the various antioxidative substances but the
cooperation of the antioxidants in human serum that
provides greater protection against attacks by free
radicals. Decreased AOA is indicative of a disturbance 
in the antioxidant system which could be due to dimin-
ished individual antioxidants. A decrease in essential
antioxidants, vitamins A and E and carotene, have been
reported in preeclampsia.8,19 The concentration of
albumin, one of the major plasma proteins that con-
tributes significantly to AOA, was decreased significantly
in preeclamptic subjects.
Wayner et al showed that the free radical trapping
capacity of albumin in plasma is 10–50%.20 The ob-
served decrease in plasma albumin can be attributed to
the proteinuria that occurs in preeclampsia. The neg-
ative correlation between albumin and AOA in con-
trols indicates that whenever AOA decreases, albumin
increases as a compensatory mechanism. But in pre-
eclamptics, due to proteinuria, albumin level decreases
and cannot compensate for the diminished AOA. These
factors associated with the reduced intake of antioxi-
dants could be the possible reason for reduced AOA
in preeclampsia. Coexistent diminution of AOA along
with hyperlipidemia and excessive lipid peroxidation
contributes to the imbalance between prooxidants and
antioxidants, leading to oxidative stress and probably
permanent endothelial dysfunction in preeclampsia.
Impairment of endothelial function observed even after
3 years in previously preeclamptic women was shown
to be reversed by ascorbic acid supplementation.21
Balanced amounts of essential and endogenous anti-
oxidants may reduce the severity of preeclampsia and
decrease the risk of future CHD.
Thus, we conclude that the hypercholesterolemia
observed in our study resulted in excessive lipid per-
oxidation and generation of free radicals. Diminution
in AOA adds to the imbalance between prooxidants
and antioxidants, resulting in oxidative stress, which
in turn may cause endothelial damage. Raised AI sug-
gests increased susceptibility to atherogenicity in pre-
eclamptics. Dyslipidemia appears to be the starting
point of this chain of events. Further studies on the
role of genetic factors (apoE polymorphism) in caus-
ing dyslipidemia may contribute to the understanding
of the mechanism underlying endothelial dysfunction
in preeclampsia.
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